Form 4: Humana Director Garratt Boosts Stake with Stock Units

Humana Director John W. Garratt increased his beneficial ownership through the acquisition of common stock and restricted stock units, primarily from deferred director fees and dividend reinvestments.

Summary

• John W. Garratt, a Director of Humana Inc., reported changes in his beneficial ownership.
• Acquired 1,685 shares of Humana Common stock (non-derivative).
• Acquired 766 Restricted Stock Units (RSUs) as part of his annual director's fee, deferred until his resignation. These RSUs represent a contingent right to receive one share of Humana Inc. common stock each.
• Acquired an additional 16 Restricted Stock Units from dividend reinvestments on vested and deferred stock units, also deferred until his resignation.
• The deferred stock units will be payable in Humana Inc. common stock on a 1-for-1 basis upon his resignation.

Sentiment

Score: 7

Explanation: The filing indicates a director's routine acquisition of company stock and restricted stock units through compensation and dividend reinvestment, which is generally a positive sign of alignment with shareholder interests, though not a direct open-market purchase.

Positives

• Director John W. Garratt increased his beneficial ownership in Humana Inc., aligning his interests with shareholders.
• The acquisition of 766 Restricted Stock Units represents deferred annual director's fees, indicating a commitment to long-term value.
• Reinvestment of dividends into an additional 16 Restricted Stock Units further demonstrates confidence in the company's performance.

Negatives

• NA

Risks

• NA

Future Outlook

NA

Management Comments

• NA

Industry Context

This Form 4 filing reflects a routine insider transaction for a director of a major health insurance company. Such filings are common and typically indicate management's ongoing equity compensation and investment activities within the company.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• Acquisition of 766 Restricted Stock Units as an annual director's fee, deferred until resignation.
• Acquisition of 16 Restricted Stock Units from dividend reinvestment on vested and deferred stock units.

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with shareholders through equity ownership.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• Payment of deferred stock units in Humana Inc. common stock upon John W. Garratt's resignation as a director.

Key Dates

Recommendation

This Form 4 details routine compensation-related equity acquisitions by a director. While it shows continued alignment of interests, it does not present new information that would fundamentally alter the investment thesis for Humana Inc. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

Humana, HUM, John W. Garratt, Director, SEC Form 4, Insider Trading, Stock Units, Restricted Stock Units, Equity Compensation, Beneficial Ownership